1-4 of 4
Carmino Antonio De Souza, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Suboptimal Cytogenetic Response (CyR) On Imatinib: First Results Of The LASOR Trial

Jorge E. Cortes, MD, Carmino Antonio De Souza, PhD, Jose Luis Lopez, MD, Manuel Ayala, MD, Eduardo Bullorsky, Xiaojun Huang, Sandip Shah, K. Govind Babu, Tomasz Sacha, MD, Israel Bendit, Zhizhou Liang, Tina Owugah, Prasanna Kumar Nidamarthy, Tomasz Szczudlo, Carmen Piccolo, MD, Philipp D. le Coutre, MD
Journal: Blood
Blood (2013) 122 (21): 95.
https://doi.org/10.1182/blood.V122.21.95.95
Published: 2013
Journal Articles

Outcome of Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Based On Early Molecular Response and Factors Associated with Early Response: 4-Year Follow-up Data From Enestnd (Evaluating Nilotinib Efficacy and Safety in Clinical Trials Newly Diagnosed Patients)

Andreas Hochhaus, MD, Timothy P. Hughes, MD, MBBS, Giuseppe Saglio, François Guilhot, Haifa Kathrin Al-Ali, MD, Giantonio Rosti, Chiaki Nakaseko, MD, PhD, Carmino Antonio De Souza, PhD, Charisse Kemp, Xiaolin Fan, PhD, Albert Hoenekopp, MD, Richard A. Larson, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2012) 120 (21): 167.
https://doi.org/10.1182/blood.V120.21.167.167
Published: 2012
Journal Articles

The Relationship Between the Regulation of TOB1 Gene with Cell Proliferation, Apoptosis and Cell Cycle in BCR-ABL Positive Cells

Cintia Do Couto Mascarenhas, MD, Anderson Ferreira Cunha, Ana Flavia Brugnerotto, Sheley Gambero, B. Sc., M. Sc., Joao Machado-Neto, MSc, Adriana S. S. Duarte, PhD, Katia B. Pagnano, MD, Fernando Ferreira Costa, MD, PhD, Carmino Antonio De Souza, PhD
Journal: Blood
Blood (2012) 120 (21): 5125.
https://doi.org/10.1182/blood.V120.21.5125.5125
Published: 2012
Journal Articles

Early Assessment of Molecular Response in Chronic Myeloid Leukemia Patients On Dasatinib After Imatinib Failure Identify Patients with Poor Cytogenetic and Molecular Responses

Katia B. Pagnano, MD, Beatriz F Ribeiro, Eliana C M Miranda, Marcia T Delamain, MD, Carmino Antonio De Souza, PhD, Gislaine O Duarte, MD, Bruna Vergilio, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Andrey dos Santos, PhD, Anderson Tavares, Irene Lorand-Metze, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3787.
https://doi.org/10.1182/blood.V120.21.3787.3787
Published: 2012